Originally published March 7 2005
U.S. BioDefense launches intellectual property search engine modeled after Google
by Mike Adams, the Health Ranger, NaturalNews Editor
U.S. BioDefense is pleased to announce that it has created “The #1 High Tech Transfer Search Engine”. The engine is modeled after Google’s functionality. When it is ready for commercial launch, it will be to assist the link between venture capitalists and researchers sharing a common database of intellectual property information.
U.S. BioDefense staff currently uses the search engine to accelerate the identification of stem cell and biodefense intellectual property acquisition programs.
T2X is a search engine facilitating innovation exchange connecting VC's, small business, and public companies seeking technologies with universities, government agencies, and scientists.
Over $30 billion is invested in innovation each year and much of the new technology developed is never put to commercial use.
T2X is an online Technology Transfer Exchange where commercial members can identify technology that is available for licensing or partnering from universities, research labs, and scientists.
Numerous tools are available on T2X.us including an abstract research for technology at the National Institutes of Health and the functionality to search for technology available for licensing.
U.S. BioDefense is a Department of Defense central contractor that researches, develops, and commercializes leading-edge biotechnology.
For additional information about our company please visit our web site at usbiodefense.com.
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the U.S. BioDefense's financial performance.
Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those referred to or implied by such statements.
In addition, actual future results may differ materially from those anticipated, depending on a variety of factors, including continued maintenance of favorable license arrangements, success of market research identifying new product opportunities, successful introduction of new products, continued product innovation, the success of enhancements to the U.S. BioDefense's brand image, sales and earnings growth, ability to attract and retain key personnel, and general economic conditions affecting consumer spending, including uncertainties relating to global political conditions, such as terrorism.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml